B7 family molecules are favorably positioned at the human maternal-fetal interface

Biology of Reproduction

Volumn 68, Issue 5, 2003, Pages 1496-1504

  Petroff, Margaret G ^a   Chen, Lieping ^b   Phillips, Teresa A ^a   Azzola, Dagmar ^c   Sedlmayr, Peter ^c   Hunt, Joan S ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

Immunology; Placenta; Pregnancy; Syncytiotrophoblast; Trophoblast

Indexed keywords

B7 ANTIGEN; B7 H1 ANTIGEN; CD86 ANTIGEN; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; IMMUNOMODULATING AGENT; MESSENGER RNA; UNCLASSIFIED DRUG;

ANTIGEN PRESENTATION; ARTICLE; CYTOTROPHOBLAST; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MATERNAL BLOOD; NORTHERN BLOTTING; PLACENTA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECOND TRIMESTER PREGNANCY; STROMA; THIRD TRIMESTER PREGNANCY;

ADULT; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; BLOOD PROTEINS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE; CELL SEPARATION; CELLS, CULTURED; DECIDUA; EMBRYO; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; MACROPHAGES; MATERNAL-FETAL EXCHANGE; MEMBRANE GLYCOPROTEINS; PEPTIDES; PLACENTA; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; RNA, MESSENGER; TROPHOBLASTS;

MAMMALIA;

EID: 0242584894     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.102.010058     Document Type: Article

References (63)

1. Phillips TA, Ni J, Pan G, Ruben SM, Wei YF, Pace JL, Hunt JS. TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J Immunol 1999; 162:6053-6059.
2. Tedesco F, Narchi G, Radillo O, Meri S, Ferrone S, Betterle C. Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins. J Immunol 1993; 151: 1562-1570.
3. King A, Hiby SE, Gardner L, Joseph S, Bowen JM, Verma S, Burrows TD, Loke YW. Recognition of trophoblast HLA class I molecules by decidual NK cell receptors - a review. Placenta 2000; 21(suppl A): S81-S85.
4. Hunt JS, Tung KSK. Immunologic aspects of fertility and infertility. In: Austen KF, Frank MM, Atkinson JP, Cantor H (eds.), Samter's Immunologic Diseases, vol. 2, 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2001: 771-785.
5. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994; 15:321-331.
6. Greenfield EA, Nguyen KA, Kuchroo VK. CD28/B7 costimulation: a review. Crit Rev Immunol 1998; 18:389-418.
7. Ward SG. CD28: a signaling perspective. Biochem J 1996; 318:361-377.
8. Chambers CA, Kuhns MS, Egen JG, Allison JP. CTLA-4-mediated inhibitions in regulation of T-cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol 2001; 19:565-594.
9. Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999; 5:1365-1369.
10. Wang S, Zhu G, Chapoval AI, Dong H, Tamada K, Ni J, Chen L. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 2000; 96:2808-2813.
11. Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K, Chen L. B7-H3: a costimulatory molecule for T-cell activation and IFN-γ production. Nat Immunol 2001; 2:269-274.
12. Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfield EA, Bourque K, Boussiotis VA, Carter LL, Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH, Freeman GJ. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001; 2:261-268.
13. Freeman GJ, Long AJ, Iwai Y, Bourque D, Chernnova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, Horton HF, Fouser L, Carter L, Ling V, Bowman MR, Carreno BM, Collins M, Wood CR, Honjo T. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192:1027-1034.
14. Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci U S A 2001; 98:13866-13871.
15. Ishida Y, Agata Y, Shibahara K, Honjo T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J 1992; 11:3887-3895.
16. Agata Y, Kawasaki A, Nishimura H, Ishida Y, Tsubata T, Yagita H, Honjo T. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 1996; 8:765-772.
17. Vibhakar R, Juan G, Traganos F, Darzynkiewicz Z, Finger LR. Activation-induced expression of human programmed death-1 gene in T-lymphocytes. Exp Cell Res 1997; 232:25-28.
18. Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999; 11: 141-151.
19. Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, Sasayama S, Mizoguchi A, Hiai H, Minato N, Honjo T. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001; 291:319-322.
20. Nishimura H, Honjo T. PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol 2001; 22:265-268.
21. Tamura H, Dong H, Zhu G, Sica GL, Flies DB, Tamada K, Chen L. B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function. Blood 2001; 97:1809-1816.
22. Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Shu G, Tamada K, Lennon VA, Celis E, Chen L. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 2002; 8:793-800.
23. Petroff MG, Chen L, Phillips TA, Hunt JS. B7 family molecules: novel immunomodulators at the maternal-fetal interface. Placenta 2002; 23 (suppl A): S95-S101.
24. Phillips TA, Ni J, Hunt JS. Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines. Placenta 2001; 22:663-672.
25. Douglas GC, King BF. Isolation of villous cytotrophoblast from human placenta using immunomagnetic microspheres. J Immunol Methods 1989; 119:259-268.
26. Petroff MG, Sedlmayr P, Azzola D, Hunt JS. Decidual macrophages are potentially susceptible to inhibition by class Ia and class Ib HLA molecules. J Reprod Immunol 2002; 56:3-17.
27. Nandan D, Reiner NE. TGF-β attenuates the class II transactivator and reveals an accessory pathway of IFN-γ action. J Immunol 1997; 158:1095-1101.
28. Benirschke K, Kaufmann P. Pathology of the Human Placenta. New York: Springer-Verlag; 2000: 16.
29. Morrish DW, Dakour J, Li H. Functional regulation of human trophoblast differentiation. J Reprod Immunol 1998; 39:179-195.
30. Bulmer JN, Morrison L, Johnson PM, Meager A. Immunohistochemical localization of interferons human placental tissues in normal, ectopic, and molar pregnancy. Am J Reprod Immunol 1990; 22:109-116.
31. Platt JS, Hunt JS. Interferon-γ gene expression in cycling and pregnant mouse uterus: temporal aspects and cellular localization. J Leukoc Biol 1998; 64:393-400.
32. Hunt JS, Petroff MG, Burnett TG. Uterine leukocytes: key players in pregnancy. Semin Cell Dev Biol 2000; 11:127-137.
33. Flaishon L, Topilski I, Shoseyov D, Hershkoviz R, Fireman E, Levo Y, Marmor S, Shachar I. Anti-inflammatory properties of low levels of IFN-γ. J Immunol 2002; 168:3707-3711.
34. Carreno BM, Collins M. The B7 family of ligands and its receptors: new pathways for costimulation and inhibition of immune responses. Annu Rev Immunol 2002; 20:29-53.
35. Iwai Y, Ishida M, Tanaka Y, Okazaki T, Honjo T, Minato N. Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade. Proc Natl Acad Sci U S A 2002; 99:12293-12297.
36. Tseng SY, Otsuji M, Gorski K, Huang X, Slansky JE, Shalabi A, Shin T, Pardoll DM, Tsuchiya H. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med 2001; 193:839-846.
37. Walker WS. Separate precursor cells for macrophages and microglia in mouse brain: immunophenotypic and immunoregulatory properties of the progeny. J Neuroimmunol 1999; 94:127-133.
38. Leifeld L, Trautwein C, Dumoulin FL, Manns MP, Sauerbruch T, Spengler U. Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure. Am J Pathol 1999; 154:1711-1720.
39. Carson MJ, Reilly CR, Sutcliffe JG, Lo D. Mature microglia resemble immature antigen-presenting cells. Glia 1998; 22:72-85.
40. Fleischer J, Soeth E, Reiling N, Grage-Griebenow E, Flad HD, Ernst M. Differential expression and function of CD80 (B7-1) and CD86 (B7-2) on human peripheral blood monocytes. Immunology 1996; 89: 592-598.
41. Inaba M, Witmer-Pack M, Inaba M, Hathcock KS, Sakuta H, Azuma M, Yagita H, Okumura K, Linsley PS, Ikehara S. The tissue distribution of the B7-2 costimulator in mice: abundant expression of dendritic cell in situ and during maturation in vitro. J Exp Med 1994; 180:1849-1860.
42. Olivares EG, Montes MJ, Oliver C, Galindo JA, Ruiz C. Cultured human decidual stromal cells express B7-1 (CD80) and B7-2 (CD86) and stimulate allogeneic T cells. Biol Reprod 1997; 57:609-615.
43. Taylor S, Bryson YJ. Impaired production of γ-interferon by newborn cells in vitro is due to a functionally immature macrophage. J Immunol 1985; 134:1493-1497.
44. Chang MY, Pollard JW, Khalili H, Goyert SM, Diamond B. Mouse placental macrophages have a decreased ability to present antigen. Proc Natl Acad Sci U S A 1993; 90:462-466.
45. Sutton L, Gadd M, Mason DY, Redman CW. Cells bearing class II MHC antigens in the human placenta and amniochorion. Immunology 1986; 58:23-29.
46. Petty RE, Hunt DW. Neonatal dendritic cells. Vaccine 1998; 16:1378-1382.
47. Varis I, Deneys V, Mazzon AM, De Bruyere M, Cornu G, Brichard B. Expression of HLA-DR, CAM and co-stimulatory molecules on cord blood monocytes. Eur J Haematol 2001; 66:107-114.
48. Hunt JS, Fishback JL. Amniochorion: immunologic aspects - a review. Am J Reprod Immunol 1989; 21:114-118.
49. Hunt JS, King CR, Wood GW. Evaluation of human chorionic trophoblast cells and placental macrophages as stimulators of maternal lymphocyte proliferation in vitro. J Reprod Immunol 1984; 6:377-391.
50. Labarrere CA, McIntyre JA, Faulk WP. Immunohistologic evidence that villitis in human normal term placentas is an immunologic lesion. Am J Obstet Gynecol 1990; 162:515-522.
51. Yang Y, Geraghty DE, Hunt JS. Cytokine regulation of HLA-G expression in human trophoblast cell lines. J Reprod Immunol 1995; 29: 179-195.
52. King A, Burrows TD, Hiby SE, Bowen JM, Joseph S, Verma S, Lim PB, Gardner L, Le Bouteiller P, Ziegler A, Uchanska-Ziegler B, Loke YW. Surface expression of HLA-C antigen by human extravillous trophoblast. Placenta 2000; 21:376-387.
53. Enomoto A, Kato K, Yagita H, Okumura K. Adoptive transfer of cytotoxic T lymphocytes induced by CD86-transfected tumor cells suppresses multi-organ metastases of C1300 neuroblastoma in mice. Cancer Immunol Immunother 1997; 44:204-210.
54. Sigal LJ, Reiser H, Rock KL. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo. J Immunol 1998; 161: 2740-2745.
55. Yu XZ, Martin PJ, Anasetti C. Role of CD28 in acute graft-versus-host disease. Blood 1998; 92:2963-2970.
56. La Motte RN, Sharpe AH, Bluestone JA, Mokyr MB. Host B7-1 and B7-2 costimulatory molecules contribute to the eradication of B7-1-transfected P815 tumor cells via a CD8+ T cell-dependent mechanism. J Immunol 1999; 162:4817-4823.
57. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12:991-1045.
58. Lenschow DJ, Bluestone JA. T cell co-stimulation and in vivo tolerance. Curr Opin Immunol 1993; 5:747-752.
59. Miller JF, Basten A. Mechanisms of tolerance to self. Curr Opin Immunol 1996; 8:815-821.
60. Grohmann U, Orabona C, Fallarino F, Vacca C, Calcinaro F, Falorni A, Candeloro P, Belladonna ML, Bianchi R, Fioretti MC, Puccetti P. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 2002; 3:1097-1101.
61. Kaufman KA, Bowen JA, Tsai AF, Bluestone JA, Hunt JS, Ober C. The CTLA-4 gene is expressed in placental fibroblasts. Mol Hum Reprod 1999; 5:84-87.
62. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B, Brown C, Mellor AL. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281:1191-1193.
63. Brown JA, Dorfman DM, Ma FR, Sullivan EL, Munoz O, Wood CR, Greenfield EA, Freeman GJ. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol 2003; 170:1257-1266.